Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
59
Frequently Asked Questions
What is Market Cap of Terns Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Terns Pharmaceuticals Inc market cap is $632.71M.
What is the 52-week high for Terns Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Terns Pharmaceuticals Inc 52 week high is $10.70 as of September 13, 2025.
What is the 52-week low for Terns Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Terns Pharmaceuticals Inc 52 week low is $1.87 as of September 13, 2025.
What is Terns Pharmaceuticals Inc stock price today?
Terns Pharmaceuticals Inc stock price today is $7.23.
What was Terns Pharmaceuticals Inc stock price yesterday?
Terns Pharmaceuticals Inc stock price yesterday was $7.44.
What is the PE ratio of Terns Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Terns Pharmaceuticals Inc’s P/E ratio is -6.92.
What is the Price-to-Book ratio of Terns Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Terns Pharmaceuticals Inc P/B ratio is 2.0719.
What is the 50-day moving average of Terns Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Terns Pharmaceuticals Inc 50-day moving average is $6.19.
How many employess does Terns Pharmaceuticals Inc has?
